109048 ⎘
Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor; Recombinant DNA-technology; DNA or RNA fragments; Modified forms thereof Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides
Treating liver disease by selectively eliminating senescent cells
#4502Treating cardiovascular disease by selectively eliminating senescent cells
#4503NANOMATERIALS
#4504Ophthalmic Delivery Device And Ophthalmic Active Agent Containing Compositions
#4505Alkali-resistant calcium phosphate/nucleic acids hybrid carrier for pest control and method to produce the particles
#4506Compositions for reducing sarcolipin expression and preventing and treating muscular dystrophy and cardiomyopathy and methods of use
#4507Modulation of alternative MDM2 splicing
#4508NOVEL CAS12B ENZYMES AND SYSTEMS
#4509Compositions and Methods for Hydroxyacid Oxidase 1 (HAO1) Gene Editing for Treating Primary Hyperoxaluria Type 1 (PH1)
#4510Agents useful in treating facioscapulohumeral muscular dystrophy
#4511AGENTS USEFUL IN TREATING FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY
#4512COMPOSITIONS AND METHODS FOR NICKING TARGET DNA SEQUENCES
#4513CRISPR therapy
#4514MRNA driven expression of RNA editors for treatment of pathologies
#4515ENRICHMENT OF GENOME-EDITED CELLS
#4516METHOD FOR SCREENING AND IDENTIFYING FUNCTIONAL LNCRNAS
#4517Targeted Critical Fluid Nanoparticles Platform for Delivery of Nucleic Acids for Treatment of HIV-1 and Other Diseases
#4518BBB-crossing lipid ligand of hetero nucleic acid
#4519ARC PROTEIN EXTRACELLULAR VESICLE NUCLEIC ACID DELIVERY PLATFORM
#4520CELLULAR COMPOSITIONS AND METHODS OF TREATMENT I
#4521Compositions and methods for treating facioscapulohumeral dystrophy
#4522METHODS OF CHANGING TRANSCRIPTIONAL OUTPUT
#4523CRISPR/Cas fusion proteins and systems
#4524Enhanced immune effector cells and use thereof
#4525Tumor immunotherapy target and application thereof
#4526Targeting P18 for mTOR-related disorders
#4527POLYPEPTIDES SELF-ASSEMBLING INTO NANOPARTICLES
#4528Aptamer Compositions and Methods of Use Thereof
#4529Treatment of primary ciliary dyskinesia with synthetic messenger RNA
#4530Composition and Methods of Controllable Co-Coupling Polypeptide Nanoparticle Delivery System for Nucleic Acid Therapeutics
#4531RNA/DNA HYBRID NANOPARTICLES MODIFIED WITH SINGLE STRANDED RNA TOEHOLDS AND USES THEREOF
#4532MULTI-FUNCTIONAL CANCER DRUG DELIVERY NANODEVICE FOR PRECISION MEDICINE
#4533Targeting macula densa cells as a new therapeutic approach for kidney disease
#4534NOVEL LIPIDS AND COMPOSITIONS FOR THE DELIVERY OF THERAPEUTICS
#4535Sequence specific antimicrobials
#4536Fusion protein between short form rod-derived cone viability factor and a hydrophilic peptide
#4537EXTRACELLULAR VESICLES AND USES THEREOF
#4538Antisense-induced exon exclusion in type VII collagen
#4539FACTOR VIII OR FACTOR IX GENE KNOCKOUT RABBIT, METHOD FOR PREPARING SAME AND USE THEREOF
#4540CRISPR logic circuits for safer and controllable gene therapies
#4541Modulation of gene expression and screening for deregulated protein expression
#4542ANTISENSE ANTIBACTERIAL COMPOUNDS AND METHODS
#4543Compositions and methods to treat cancer
#4544MICRORNA TARGETING AGENT FOR TREATMENT OF HEART DISEASE
#4545DIFFERENTIAL KNOCKOUT OF AN ALLELE OF A HETEROZYGOUS ELANE GENE - II
#4546RNA-AIDED IMMUNOTHERAPEUTICS
#4547METHODS FOR TREATING SICKLE CELL DISEASE
#4548siRNAs WITH AT LEAST TWO LIGANDS AT DIFFERENT ENDS
#4549Compositions and methods for disrupting the molecular mechanisms associated with mitochondrial dysfunction and neurodegenerative disease
#4550ANTI-TUMOR COMPOSITION COMPRISING GM-CSF GENE, Flt3L-TRAIL FUSION GENE, shRNA INHIBITING TGF-ß EXPRESSION, AND shRNA INHIBITING HSP EXPRESSION
#4551CRISPR-Based Synthetic Gene Circuits as Next Generation Gene Therapy of Inner Ear
#4552HAEMATOPOIETIC STEM CELL TREATMENT
#4553Methods for treating NLRP3 inflammasome-associated diseases, and methods of identifying agents useful therefor
#4554Compositions and methods for treating pulmonary vascular disease
#4555Beta-catenin inhibitors in cancer immunotherapy
#4556MiRNAs for treatment and in vitro diagnosis of drug resistant tumors
#4557TRIPLE FUNCTION ADENO-ASSOCIATED VIRUS (AAV)VECTORS FOR THE TREATMENT OF C9ORF72 ASSOCIATED DISEASES
#4558COMPOSITIONS AND METHODS FOR RNA-TEMPLATED EDITING IN PLANTS
#4559Optimized CRISPR-Cas nucleases and base editors and methods of use thereof
#4560Methods for increasing observed editing in bacteria
#4561Gene editing methods with increased knock-in efficiency
#4562Use of trinucleotide repeat RNAs to treat cancer
#4563REDUCED SIZE SELF-DELIVERING RNAI COMPOUNDS
#4564PLANT SRNA EXTRACT FOR USE AS AN IMMUNOSUPPRESSIVE AGENT
#4565Synthetic near-threshold translational repressors
#4566ANTISENSE POLYNUCLEOTIDES TO INDUCE EXON SKIPPING AND METHOD OF TREATING DYSTROPHIES
#4567Method for Site-Specific Mutagenesis of Medicago Sativa Genes by Using CRISPR/Cas9 System
#4568Systems, methods, and compounds for providing chaperone activity to proteins
#4569METHODS AND COMPOSITIONS FOR INHIBITING NECROPTOSIS IN NEUROVASCULAR AND/OR NEURODEGENERATIVE DISEASES OR DISORDERS
#4570COMPOSITIONS AND METHODS FOR MODIFYING REGULATORY T CELLS
#4571SiRNAs with vinylphosphonate at the 5′ end of the antisense strand
#4572Antisense nucleic acids
#4573Selective Antisense Compounds and Uses Thereof
#4574Oligomeric Compounds Comprising Bicyclic Nucleotides and Uses Thereof
#4575Use of thermostable RNA polymerases to produce RNAs having reduced immunogenicity
#4576Artificially manipulated immune cell
#4577CD71 binding fibronectin type III domains
#4578Modification of Immune Cells to Increase Activity
#4579Mir-17˜92 as therapeutic or diagnostic target of motor neuron (MN) degeneration diseases
#4580Targeted delivery of therapeutic agents to human adipocytes
#4581Altering microbial populations and modifying microbiota
#4582Fusions and method for detecting same
#4583Treatment of angiogenesis disorders
#4584Methods and compositions related to T-cell activity
#4585PLANT GENOME EDITING
#4586MAIZE FEMALE PARENT HAPLOID MAJOR EFFECT INDUCING GENE AND APPLICATION
#4587Compositions and methods for gene editing
#4588FIDGETIN-LIKE 2 AS A TARGET TO ENHANCE WOUND HEALING
#4589Methods and compositions for reducing immunosuppression by tumor cells
#4590Materials and methods for the delivery of therapeutic nucleic acids to tissues
#4591COMPOUNDS AND METHODS FOR REDUCING SPDEF EXPRESSION
#4592Oligonucleotide therapy for Leber congenital amaurosis
#4593METHODS AND MEANS FOR EFFICIENT SKIPPING OF AT LEAST ONE OF THE FOLLOWING EXONS OF THE HUMAN DUCHENNE MUSCULAR DYSTROPHY GENE: 43, 46, 50-53
#4594Methods and compositions for the specific inhibition of Complement Component 5(C5) by double-stranded RNA
#4595RNAI TARGET GENE THAT IS HIGHLY LETHAL TO APHIDS AND USE THEREOF
#4596Two-tailed self-delivering siRNA
#4597Modulation of Huntington expression
#4598Cancer chemoprevention with STAT3 blockers
#4599Structural domains of antisense RNA molecules up-regulating translation
#4600OLIGONUCLEOTIDE ANALOGUES HAVING MODIFIED INTERSUBUNIT LINKAGES AND/OR TERMINAL GROUPS
#4601Peptide oligonucleotide conjugates
#4602PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER
#4603Treatment of Fuchs' endothelial corneal dystrophy
#4604G-quadruplex-containing antisense oligonucleotides
#4605NOVEL CRISPR RNA TARGETING ENZYMES AND SYSTEMS AND USES THEREOF
#4606TREATMENT OF A DISEASE OF THE GASTROINTESTINAL TRACT WITH AN IMMUNE MODULATORY AGENT RELEASED USING AN INGESTIBLE DEVICE
#4607Exon skipping oligomer conjugates for muscular dystrophy
#4608Exon skipping oligomer conjugates for muscular dystrophy
#4609GENE EDITING FOR AUTOIMMUNE DISORDERS
#4610Treatment of aberrant fibroblast proliferation
#4611COMPOSITIONS AND METHODS FOR INHIBITION OF NUCLEAR-PENETRATING ANTIBODIES
#4612COMPOSITIONS AND METHODS FOR MEMBRANE PROTEIN DELIVERY
#4613Targeting chromosomal instability and downstream cytosolic DNA signaling for cancer treatment
#4614Structuring fats and methods of producing structuring fats
#4615Method for reducing the expression of NKCC1 in a subject
#4616Compositions and methods for RNA-encoded DNA-replacement of alleles
#4617GIN RECOMBINASE VARIANTS
#4618TYPE V CRISPR-CAS BASE EDITORS AND METHODS OF USE THEREOF
#4619METHODS OF MODULATING ANTISENSE ACTIVITY
#4620Ischemic-lesion-site-specific gene therapy
#4621COMPOSITIONS AND METHODS FOR GENE EDITING BY TARGETING FIBRINOGEN-ALPHA
#4622COMPOSITIONS AND METHODS
#4623Antisense oligomer compounds
#4624Chiral control
#4625Method for producing nucleic acid molecule, biomaterial, and method for producing biomaterial
#4626Increasing RNAi efficiency through single nucleotide mismatches
#4627CLOSED PROCESS FOR EXPANSION AND GENE EDITING OF TUMOR INFILTRATING LYMPHOCYTES AND USES OF SAME IN IMMUNOTHERAPY
#4628CELLS EXPRESSING A CHIMERIC ANTIGEN RECEPTOR OR ENGINEERED TCR AND COMPRISING A NUCLEOTIDE SEQUENCE WHICH IS SELECTIVELY EXPRESSED
#4629Inhibitors of metastasis
#4630EXOSOMES DERIVED FROM CORTICAL BONE STEM CELLS CAN AUGMENT HEART FUNCTION AFTER CARDIAC INJURY
#4631Engineered immune cells resistant to tumor microenvironment
#4632Methods for treatment or prevention of leukemia
#4633Heterocyclic carboxylate compounds as glycolate oxidase inhibitors
#4634Lipids for use in lipid nanoparticle formulations
#4635METHODS AND COMPOSITIONS OF INSECT CONTROL
#4636METHODS FOR IDENTIFYING THERAPEUTIC AGENTS WHICH INTERACT WITH STK24
#4637Oligonucleotides for modulating Tau expression
#4638Mammalian cells for producing a secreted protein
#4639METHODS FOR THE IN VIVO PRODUCTION OF SINGLE STRANDED DNA AND USES THEREOF
#4640Uses for prevention or treatment of brain diseases using microRNA
#4641Antisense oligonucleotides for the treatment of usher syndrome type 2
#4642POLYNUCLEOTIDE AGENTS TARGETING SERPINC1 (AT3) AND METHODS OF USE THEREOF
#4643Nucleic acids for inhibiting expression of LPA in a cell
#4644Modified double-stranded donor templates
#4645Lipids for use in lipid nanoparticle formulations
#4646Lipids for use in lipid nanoparticle formulations
#4647METHODS AND COMPOSITIONS FOR TREATING TUMOR CELLS
#4648Methods for treating triple-negative breast cancer
#4649METHOD FOR PRODUCING SINGLE-STRAND RNA
#4650Ras opposite (ROP) and related nucleic acid molecules that confer resistance to coleopteran and/or hemipteran pests
#4651MODULATING AMINO ACID CONTENT IN A PLANT
#4652Regulation of translation of expressed genes
#4653CHANNEL MODULATORS
#4654Chiral design
#4655Compounds and compositions including phosphorothioated oligodeoxynucleotide, and methods of use thereof
#4656O-METHYL RICH FULLY STABILIZED OLIGONUCLEOTIDES
#4657Targeting cancer-associated long non-coding RNAs
#4658Composition for delivering nucleic acid and nucleic acid-containing composition
#4659Antisense oligonucleotides for the treatment of Stargardt disease
#4660Thiophosphoramidites
#4661Variants of CAS12A nucleases and methods of making and use thereof
#4662CRISPR/Cas9-Mediated Exon-Skipping Approach for USH2A-Associated Usher Syndrome
#4663RNA nanoparticles for brain tumor treatment
#4664METHODS FOR TREATING INFLAMMATION
#4665Extraction of plant source “medicinal soup” and manual preparation of “herbal medicine” and related products
#4666Methods for modulating regulatory T cells, regulatory b cells, and immune responses using modulators of the april-taci interaction
#4667Methods of attenuating an immune response by inhibition of BFL1
#4668MicroRNA (miRNA) and Downstream Targets for Diagnostic and Therapeutic Purposes
#4669COMPOSITIONS AND METHODS TO PROMOTE THYMIC REGENERATION
#4670Cationic polymers
#4671Detection of nucleic acids
#4672Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#4673Simultaneous gene silencing and suppressing gene silencing in ihe same cell
#4674TARGETED AUGMENTATION OF NUCLEAR GENE OUTPUT
#4675RNAi-MEDIATED INHIBITION OF HIF1A FOR TREATMENT OF OCULAR ANGIOGENESIS
#4676MicroRNA Compounds and Methods for Modulating MIR-122
#4677RNA Modulating Oligonucleotides with Improved Characteristics for the Treatment of Duchenne and Becker Muscular Dystrophy
#4678Apolipoprotein C3 (APOC3) iRNA compositions and methods of use thereof
#4679COMPOSITIONS COMPRISING EICOSAPENTAENOIC ACID AND MIPOMERSEN AND METHODS OF USE THEREOF
#4680FN3 domain-siRNA conjugates and uses thereof
#4681BRANCHED LIPID CONJUGATES OF siRNA FOR SPECIFIC TISSUE DELIVERY
#4682Treatment for aggressive cancers by targeting C9ORF72
#4683APPLICATION OF COMPOUND OR TRADITIONAL CHINESE MEDICINE EXTRACT IN PREPARATION OF NUCLEIC ACID DELIVERY AGENT AND RELATED PRODUCTS THEREOF
#4684SHRNA EXPRESSION CASSETTE, POLYNUCLEOTIDE SEQUENCE CARRYING SAME, AND APPLICATION THEREOF
#4685NON-COVALENT SYSTEMS AND METHODS FOR DNA EDITING
#4686FORMULATIONS FOR GASTROINTESTINAL DELIVERY OF OLIGONUCLEOTIDES
#4687Programmable nuclease compositions and methods of use thereof
#4688Method for confirming introduction of foreign gene into cells and method for manufacturing introduction foreign gene into cells
#4689Methods and compositions for a HIV based delivery system
#4690Nucleic acid construct for in vitro and in vivo gene expression
#4691Cancer treatment by MALAT1 inhibition
#4692COMPOSITIONS AND METHODS FOR NUCLEIC ACID TRANSFER
#4693Rotationally sequestered translators
#4694TARGETED GENE ACTIVATION USING MODIFIED GUIDE RNA
#4695EXON SKIPPING OLIGOMERS AND OLIGOMER CONJUGATES FOR MUSCULAR DYSTROPHY
#4696SIRT1-saRNA compositions and methods of use
#4697Compositions and methods for modulating MECP2 expression
#4698Promotion of cardiomyocyte proliferation and regenerative treatment of the heart by inhibition of microRNA-128
#4699DESIGNING SENSITIVE, SPECIFIC, AND OPTIMALLY ACTIVE BINDING MOLECULES FOR DIAGNOSTICS AND THERAPEUTICS
#4700Protein macrocyclization
#4701Engineered cascade components and cascade complexes
#4702Personalized cells, tissues, and organs for transplantation from a humanized, bespoke, designated-pathogen free, (non-human) donor and methods and products relating to same
#4703Pharmaceutical composition comprising expression or activity inhibitor of c-src for preventing or treating synucleinopathy
#4704APPLICATION OF COMPOUND OR TRADITIONAL CHINESE MEDICINE EXTRACT IN PREPARATION OF NUCLEIC ACID DELIVERY AGENT, AND RELATED PRODUCTS
#4705RNAi agents for hepatitis B virus infection
#4706Methods for Treatment of Alport Syndrome
#4707Methods and compositions for enhancing anti-tumor immunity by targeting steroidogenesis
#4708FUNCTIONAL TARGETS OF MIR-6891-5P & APPLICATIONS THEREOF
#4709MULTICISTRONIC EXPRESSION CONSTRUCTS
#4710High efficient delivery of plasmid DNA into human and vertebrate primary cells in vitro and in vivo by nanocomplexes
#4711Use of MIR101 or MIR128 in the treatment of seizure disorders
#4712METHODS OF MODULATING NKX6.3
#4713MicroRNA-based logic gates and uses thereof
#4714Trans-activated functional RNA by strand displacement and uses thereof
#4715Methods for treating brain injury
#4716Modified oligonucleotides for use in treatment of tauopathies
#4717HETERODUPLEX NUCLEIC ACID MOLECULES AND USES THEREOF
#4718Modified Oligonucleotides for Treatment of Polycystic Kidney Disease
#4719Modulation of transthyretin expression
#4720Trimethylglycylglycerin compositions and their use in developing anti-cancer drugs and RNA vaccines
#4721Methods and compositions for the specific inhibition of antithrombin 3 (AT3) by double-stranded RNA
#4722Micro RNA expression constructs and uses thereof
#4723ANTISENSE OLIGONUCLEOTIDES TARGETING SREBP1
#4724OLIGONUCLEOTIDES FOR MODULATING ERC1 EXPRESSION
#4725OLIGONUCLEOTIDES FOR MODULATING GSK3B EXPRESSION
#4726OLIGONUCLEOTIDES FOR MODULATING PIAS4 EXPRESSION
#4727INTEGRIN TARGETING LIGANDS AND USES THEREOF
#4728ENGINEERED GUT MICROBES AND USES THEREOF
#4729PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING LIVER CANCER
#4730LOADING OF EXTRACELLULAR VESICLES THROUGH IMPARTING OF MECHANICAL SHEAR
#4731Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#4732Modified Guide RNAs for Gene Editing
#4733Therapeutic oligonucleotides
#4734Compositions and methods for modulating apolipoprotein (a) expression
#4735ANTISENSE ANTIBIOTICS AND BACTERIAL SECRETION BASED DELIVERY SYSTEM TO ELIMINATE DRUG-RESISTANT BACTERIA
#4736TRNA/pre-miRNA compositions and methods for treating hepatocellular carcinoma
#4737Methods and compositions for treating inflammatory diseases
#4738Modulation of alpha synuclein expression
#4739Inhibitors Of Lactate Transporters For Use In The Treatment Of Inflammatory Diseases
#4740OLIGODENDROCYTE-SPECIFIC PROMOTER, MIRNA SPECIFIC TO PLP1 GENE,VECTOR INCLUDING SAID PROMOTER AND/OR MIRNA, AND PHARMACEUTICAL COMPOSITION INCLUDING SAID VECTOR
#4741Modulation of frataxin expression
#4742COMPOSITIONS AND METHODS FOR INHIBITING EXPRESSION OF THE ALAS1 GENE
#4743Methods and compositions for targeted genomic insertion
#4744Therapeutic agent for fibrosis
#4745Method for inducing exon skipping by genome editing
#4746Means and methods to treat inflammatory diseases
#4747ENHANCED IMMUNE EFFECTOR CELLS AND USE THEREOF
#4748Medicine for treating disorders of glucose and/or lipid metabolism and a method of treating glucose and/or lipid metabolic disorders
#4749MPS PEPTIDES AND USE THEREOF
#4750COMPOSITIONS AND METHODS DIRECTED TO TREATING LIVER FIBROSIS
#4751Use of miR-21 in preparation of drug for treating intrauterine adhesion and/or thin endometrium
#4752Branched oligonucleotides
#4753Edible plant-derived nanoparticles for regulation of gut microbiota
#4754Compositions and methods for the treatment of cancer using a CD8 engineered T cell therapy
#4755COMPOSITIONS AND METHODS FOR THE TREATMENT OF CANCER USING A TET2 ENGINEERED T CELL THERAPY
#4756IMPROVED BCL11A MICRORNAS FOR TREATING HEMOGLOBINOPATHIES
#4757Microrna and uses thereof in prevention and/or treatment of fibroplasia medical sign and/or syndrome
#4758Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription
#4759CRISPR-CAS COMPONENT SYSTEMS, METHODS AND COMPOSITIONS FOR SEQUENCE MANIPULATION
#4760Nucleic acid linked to a trivalent glycoconjugate
#4761Anti-connexin compounds targeted to connexins and methods of use thereof
#4762Modulators of APOL1 expression
#4763TRANSCRIPTION MODULATION IN ANIMALS USING CRISPR/CAS SYSTEMS DELIVERED BY LIPID NANOPARTICLES
#4764ANTISENSE OLIGONUCLEOTIDES FOR RNA EDITING
#4765Inhibition of mir-22 miRNA by APT-110
#4766Antisense oligonucleotide compositions
#4767Nucleic acid inhibiting expression of the MEX3B gene, MEX3B gene expression inhibitor, method for inhibiting MEX3B gene expression, and prophylactic or therapeutic agent for disease caused by MEX3B gene expression
#4768GUIDE RNA WITH CHEMICAL MODIFICATIONS
#4769Near-infrared photothermally activated CRISPR/CAS9 genome editing machine
#4770GENETICALLY ENGINEERED T CELLS HAVING IMPROVED PERSISTENCE IN CULTURE
#4771NOVEL MEANS AND METHODS FOR TREATING NEURODEGENERATIVE DISEASES
#4772COMPOSITIONS AND METHODS FOR DELIVERY AND EXPRESSION OF SMALL INHIBITORY PEPTIDES AND USE THEREOF
#4773Exon skipping oligomer conjugates for muscular dystrophy
#4774Motile sperm domain containing protein 2 and inflammation
#4775Sequence-specific in vivo cell targeting
#4776COMPOSITIONS FOR DRG-SPECIFIC REDUCTION OF TRANSGENE EXPRESSION
#4777Vesicles comprising a PTEN inhibitor and uses of same
#4778Biomarkers predictive of anti-immune checkpoint response
#4779Methods for immunoregulation by modulating plasminogen-apple-nematode (PAN) domain-containing proteins
#4780TREATMENT TARGETING ONCOLOGY AND NEURODEGENERATION
#4781METHODS FOR IDENTIFICATION OF GENES AND GENETIC VARIANTS FOR COMPLEX PHENOTYPES USING SINGLE CELL ATLASES AND USES OF THE GENES AND VARIANTS THEREOF
#4782Delivery across cell plasma membranes
#4783PHARMACEUTICAL COMPOSITION
#4784MICRORNA 584-5P COMPOSITIONS AND METHODS FOR TREATING CANCER
#4785Mobile-CRISPRi plasmids and related methods
#4786Targeted trans-splicing using CRISPR/Cas13
#4787Modified oligonucleotides targeting SNPs
#4788Compositions for modulating Tau expression
#4789MicroRNA hsa-miR-665 in cardiac hypertrophy
#4790Gene-regulating compositions and methods for improved immunotherapy
#4791Identifying Epigenetic And Transcriptional Targets To Prevent And Reverse T Cell Exhaustion
#4792NFAT binding polynucleotides
#4793Fermentation process
#4794GENE AUGMENTATION THERAPIES FOR INHERITED RETINAL DEGENERATION CAUSED BY MUTATIONS IN THE PRPF31 GENE
#4795Hexameric tetrahedral RNA nanostructures
#4796MODIFIED FACTOR VII POLYPEPTIDES FOR SUBCUTANEOUS ADMINISTRATION AND ON-DEMAND TREATMENT
#4797RECOMBINANT GLUT1 ADENO-ASSOCIATED VIRAL VECTOR CONSTRUCTS AND RELATED METHODS FOR RESTORING GLUT1 EXPRESSION
#4798Blockade of miR4661-3p binding to IL-17A mRNA with site-specific target site blocker prevents neuro-inflammatory-mediated disease
#4799Pharmaceutical carriers containing miRNAs for use in the treatment of renal cancer
#4800Methods and compositions for control of arthropod pests